Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of systemic Chemotherapy on high-risk stage II and III Mucnious colon cancer. CHEMUCCA study part I.
Trinidad-Gutiérrez I, Vázquez-Borrego MC, Aguilera-Fernández E, Velez-Castaño JE, Muriel-López CE, Rodríguez-Ortíz L, Gómez A, Berchez-Moreno F, Hervás C, Romero-Ruiz A, Arjona-Sánchez Á. Trinidad-Gutiérrez I, et al. Among authors: vazquez borrego mc. Eur J Surg Oncol. 2024 Nov;50(11):108642. doi: 10.1016/j.ejso.2024.108642. Epub 2024 Aug 24. Eur J Surg Oncol. 2024. PMID: 39213699
Breaking the Mucin Barrier: A New Affinity Chromatography-Mass Spectrometry Approach to Unveil Potential Cell Markers and Pathways Altered in Pseudomyxoma Peritonei.
Romero-Ruiz A, Granados-Rodríguez M, Bura FI, Valenzuela-Molina F, Rufián-Andújar B, Martínez-López A, Rodríguez-Ortiz L, Ortega-Salas R, Torres-Martínez M, Moreno-Serrano A, Castaño J, Michán C, Alhama J, Vázquez-Borrego MC, Arjona-Sánchez Á. Romero-Ruiz A, et al. Among authors: vazquez borrego mc. Biol Proced Online. 2024 May 15;26(1):13. doi: 10.1186/s12575-024-00239-0. Biol Proced Online. 2024. PMID: 38750435 Free PMC article.
Undetectable circulating tumor DNA confirms the inability of pseudomyxoma peritonei to systemic dissemination.
Villarejo Campos P, Vázquez-Borrego MC, Martínez-Quintanilla J, Cabot D, Romero-Ruíz A, Granados-Rodríguez M, Bura FI, García-Arranz M, García-Olmo D, Arjona-Sánchez A. Villarejo Campos P, et al. Among authors: vazquez borrego mc. Eur J Surg Oncol. 2024 Jul;50(7):108395. doi: 10.1016/j.ejso.2024.108395. Epub 2024 May 9. Eur J Surg Oncol. 2024. PMID: 38735236
Integrative clinical, hormonal, and molecular data associate with invasiveness in acromegaly: REMAH study.
Sampedro-Nuñez M, Herrera-Martínez AD, Ibáñez-Costa A, Rivero-Cortés E, Venegas E, Robledo M, Martínez-Hernández R, García-Martínez A, Gil J, Jordà M, López-Fernández J, Gavilán I, Maraver S, Marqués-Pamies M, Cámara R, Fajardo-Montañana C, Valassi E, Dios E, Aulinas A, Biagetti B, Álvarez Escola C, Araujo-Castro M, Blanco C, Paz M, Villar-Taibo R, Álvarez CV, Gaztambide S, Webb SM, Castaño L, Bernabéu I, Picó A, Gálvez MÁ, Soto-Moreno A, Puig-Domingo M, Castaño JP, Marazuela M, Luque RM; REMAH investigators. Sampedro-Nuñez M, et al. Eur J Endocrinol. 2024 Jun 5;190(6):421-433. doi: 10.1093/ejendo/lvae045. Eur J Endocrinol. 2024. PMID: 38701338
Intra-tumoural bromelain and N-acetylcysteine for recurrent and unresectable pseudomyxoma peritonei: phase I/II trial.
Rodríguez-Ortiz L, Vázquez-Borrego MC, Bura FI, Granados-Rodríguez M, Valenzuela-Molina F, Rufián-Andújar B, Martínez-López A, Ortega-Salas R, Espejo-Herrero JJ, Romero-Ruiz A, Arjona-Sánchez Á. Rodríguez-Ortiz L, et al. Among authors: vazquez borrego mc. Br J Surg. 2024 Mar 2;111(3):znae045. doi: 10.1093/bjs/znae045. Br J Surg. 2024. PMID: 38477594 Clinical Trial. No abstract available.
Antitumor effect of a small-molecule inhibitor of KRASG12D in xenograft models of mucinous appendicular neoplasms.
Vázquez-Borrego MC, Granados-Rodríguez M, Bura FI, Martínez-López A, Rufián-Andújar B, Valenzuela-Molina F, Rodríguez-Ortiz L, Haro-Yuste S, Moreno-Serrano A, Ortega-Salas R, Pineda-Reyes R, Michán C, Alhama J, Romero-Ruiz A, Arjona-Sánchez Á. Vázquez-Borrego MC, et al. Exp Hematol Oncol. 2023 Dec 8;12(1):102. doi: 10.1186/s40164-023-00465-4. Exp Hematol Oncol. 2023. PMID: 38066554 Free PMC article.
Correction: Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study.
Durán-Martínez M, Gómez-Dueñas G, Rodriguez-Ortíz L, Sanchez-Hidalgo JM, Gordón-Suárez A, Casado-Adam Á, Rufián-Peña S, Valenzuela-Molina F, Rufián-Andujar B, Vázquez-Borrego MC, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez Á. Durán-Martínez M, et al. Among authors: vazquez borrego mc. Surg Endosc. 2024 Jan;38(1):471. doi: 10.1007/s00464-023-10576-y. Surg Endosc. 2024. PMID: 37935922 No abstract available.
Laparoscopic versus open approach for interval cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in advanced epithelial ovarian cancer: a matched comparative study.
Durán-Martínez M, Gómez-Dueñas G, Rodriguez-Ortíz L, Sanchez-Hidalgo JM, Gordón-Suárez A, Casado-Adam Á, Rufián-Peña S, Valenzuela-Molina F, Rufián-Andujar B, Vázquez-Borrego MC, Romero-Ruiz A, Briceño-Delgado J, Arjona-Sánchez Á. Durán-Martínez M, et al. Among authors: vazquez borrego mc. Surg Endosc. 2024 Jan;38(1):66-74. doi: 10.1007/s00464-023-10508-w. Epub 2023 Oct 30. Surg Endosc. 2024. PMID: 37903884
Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry.
Arjona-Sanchez A, Aziz O, Passot G, Salti G, Serrano A, Esquivel J, Van der Speeten K, Sommariva A, Kazi M, Shariff U, Martínez-Regueira F, Piso P, Yonemura Y, Turaga K, Sgarbura O, Avanish Saklani A, Tonello M, Rodriguez-Ortiz L, Vazquez-Borrego MC, Romero-Ruiz A, Glehen O; International Laparoscopic PSOGI Registry. Arjona-Sanchez A, et al. Among authors: vazquez borrego mc. Eur J Surg Oncol. 2023 Oct;49(10):107001. doi: 10.1016/j.ejso.2023.107001. Epub 2023 Aug 3. Eur J Surg Oncol. 2023. PMID: 37579618
40 results